Literature DB >> 6458430

Two immunologically distinct forms of late-onset hypogammaglobulinaemia.

T A Platts-Mills, G C De Gast, A D Webster, G L Asherson, S R Wilkins.   

Abstract

Most patients with late-onset bypogammaglobulinaemia have normal numbers of B cells. In addition, some of these patients have been shown to have circulating T cells which suppress immunolobulin production in vitro. From our present studies on a large series of patients it appears that these two findings distinguish two separate groups of patients. The majority of the patients have circulating B cells which are 'immature' in the sense that they produce IgM but very little IgG or IgA in vitro. These patients also fail to produce IgA in vivo but their T cells show normal function in vitro and normal T cell markers. Patients with the second form of the disease, including those with associated thymoma, have very few circulating B cells, and relatively preserved IgA production in vivo. In our series it was only this minority of patients whose T cells showed abnormal markers and increased suppressor activity in vitro.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6458430      PMCID: PMC1537335     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  16 in total

1.  Suppressor T cells in the pathogenesis of hypogammaglobulinemia associated with a thymoma.

Authors:  T A Waldmann; S Broder; M Durm; M Blackman; R Krakauer; B Meade
Journal:  Trans Assoc Am Physicians       Date:  1975

2.  Intracellular immunoglobulin production in vitro by lymphocytes from patients with hypogammaglobulinaemia and their effect on normal lymphocytes.

Authors:  B C Broom; E G De la Concha; A D Webster; G J Janossy; G L Asherson
Journal:  Clin Exp Immunol       Date:  1976-01       Impact factor: 4.330

3.  Failure of B lymphocytes in human blood to regenerate surface immunoglobulin after its removal by antibody.

Authors:  K A Ault; E R Unanue
Journal:  J Immunol       Date:  1977-07       Impact factor: 5.422

4.  Quantitative measurements of T- and B-cell function in "variable" primary hypogammaglobulinaemia: evidence for a consistent B-cell defect.

Authors:  E G de la Concha; G Oldham; A D Webster; G L Asherson; T A Platts-Mills
Journal:  Clin Exp Immunol       Date:  1977-02       Impact factor: 4.330

5.  Lymphocytes suppressing both immunoglobulin production and erythroid differentiation in hypogammaglobulinaemia.

Authors:  S D Litwin; E D Zanjani
Journal:  Nature       Date:  1977-03-03       Impact factor: 49.962

6.  Heterogeneity of "acquired" or common variable agammaglobulinemia.

Authors:  R S Geha; E Schneeberger; E Merler; F S Rosen
Journal:  N Engl J Med       Date:  1974-07-04       Impact factor: 91.245

7.  Role of suppressor T cells in pathogenesis of common variable hypogammaglobulinaemia.

Authors:  T A Waldmann; M Durm; S Broder; M Blackman; R M Blaese; W Strober
Journal:  Lancet       Date:  1974-09-14       Impact factor: 79.321

8.  IgA and IgA diphtheria antitoxin responses from human tonsil lymphocytes.

Authors:  T A Platts-Mills; K Ishizaka
Journal:  J Immunol       Date:  1975-03       Impact factor: 5.422

9.  Functional 'immaturity' of isolated B cells from patients with hypogammaglobulinaemia.

Authors:  G C De Gast; S R Wilkins; A D Webster; A Rickinson; T A Platts-Mills
Journal:  Clin Exp Immunol       Date:  1980-12       Impact factor: 4.330

10.  The IgA system. I. Studies of the transport and immunochemistry of IgA in the saliva.

Authors:  M A South; M D Cooper; F A Wollheim; R Hong; R A Good
Journal:  J Exp Med       Date:  1966-04-01       Impact factor: 14.307

View more
  12 in total

Review 1.  X-linked agammaglobulinemia.

Authors:  M E Conley; J Rohrer; Y Minegishi
Journal:  Clin Rev Allergy Immunol       Date:  2000-10       Impact factor: 8.667

2.  Interleukin-4 suppresses immunoglobulin production by peripheral blood lymphocytes of patients with common variable immunodeficiency (CVI) induced by supernatants of T cell clones.

Authors:  G Pastorelli; M G Roncarolo; J L Touraine; F Rousset; J Pene; J E de Vries
Journal:  Clin Exp Immunol       Date:  1989-12       Impact factor: 4.330

3.  Role of retroviruses in acquired hypogammaglobulinaemia.

Authors:  G P Spickett; M Millrain; R Beattie; M North; J Griffiths; S Patterson; A D Webster
Journal:  Clin Exp Immunol       Date:  1988-11       Impact factor: 4.330

4.  The capacity of interleukin-4 to induce in vitro IgE synthesis by B cells of patients with common variable immunodeficiency.

Authors:  G Pastorelli; M G Roncarolo; C Peronne; P A Tovo; J E de Vries
Journal:  Clin Exp Immunol       Date:  1990-10       Impact factor: 4.330

Review 5.  Good's syndrome remains a mystery after 55 years: A systematic review of the scientific evidence.

Authors:  Theodoros Kelesidis; Otto Yang
Journal:  Clin Immunol       Date:  2010-02-10       Impact factor: 3.969

6.  Accessory and T cell defects in acquired and inherited hypogammaglobulinaemia.

Authors:  K E Rozynska; G P Spickett; M Millrain; A Edwards; A Bryant; A D Webster; J Farrant
Journal:  Clin Exp Immunol       Date:  1989-10       Impact factor: 4.330

7.  Evaluation of test immunisation in the assessment of antibody deficiency syndromes.

Authors:  A D Webster; A A Latif; M K Brenner; D Bird
Journal:  Br Med J (Clin Res Ed)       Date:  1984-06-23

8.  Hydroxyurea increases in vitro, antigen-independent B cell development in bone marrow.

Authors:  P P Le Bouteiller; G L Ashersn; A J Edwards
Journal:  Clin Exp Immunol       Date:  1982-09       Impact factor: 4.330

9.  Thymoma and hypogammaglobulinaemia with and without T suppressor cells.

Authors:  M K Brenner; J G Reittie; H R Chadda; A Pollock; G L Asherson
Journal:  Clin Exp Immunol       Date:  1984-12       Impact factor: 4.330

10.  Defective low-density cells of dendritic morphology from the blood of patients with common variable hypogammaglobulinaemia: low immunoglobulin production on stimulation of normal B cells.

Authors:  J Farrant; A E Bryant; A M Lever; A J Edwards; S C Knight; A D Webster
Journal:  Clin Exp Immunol       Date:  1985-07       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.